Skip to main content

16 September 2025

Last updated: Tuesday 16 September 2025

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

Diurnal Group Plc
Sidley Austin LLP
Omnix Medical
Cell Therapy Catapult Ltd
BDO UK LLP
Marks and Clerk LLP
Themis Bioscience GmbH
Novasecta Ltd
iTeos Therapeutics SA
ERA Consulting Group

Interviewees and Contributers

Maarten Meulenbelt
Richard Pops
Henrik Jensen
John Lin
Reisa Sperling
Dave Tapolczay
Bernd Muehlenweg
Erik van den Berg
Arthur Oubrie
Richard Francis

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Oculis appoints two medical advisors

Tuesday 16 September 2025

UNFPA has new executive director

Tuesday 16 September 2025

Molecular Partners appoints CSO

Tuesday 16 September 2025

TRIMTECH forms scientific advisory board

Tuesday 16 September 2025

Shaun Grady to chair UK BioIndustry Association

Tuesday 16 September 2025

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2025 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form